SAFETY OF ERYTHROMYCIN VERSUS CLARITHROMYCIN IN ADULTS AND ADOLESCENTS WITH PNEUMONIA: META-ANALYSIS

• At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
• Type: Poster
• By: ELJAALY, Khalid (King Abdulaziz University, Pharmacy Practice, Saudi Arabia)
• Co-author(s): Khalid Eljaaly: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia;Pharmacy Practice & Science, University of Arizona, Tucson, United States
  Ahmed Botaish: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
  Fawaz Bahobail: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
  Mohamed Almehmadi: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
  Ziyad Assabban: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
  Abrar Thabit: Pharmacy Practice, King Abdulaziz University, Jeddah, Saudi Arabia
  
• Abstract:

  Background

  It is debatable whether erythromycin is associated with more adverse drug reactions (ADRs) compared to clarithromycin, and both are recommended in clinical practice guidelines

  Methods

  Two investigators independently searched PubMed, EMBASE and Cochrane Library databases through Feb 07, 2019. Randomized-controlled trials (RCTs) comparing
  ..

The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login